亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Relationships of Proton Pump Inhibitor‐Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study

CYP2C19型 埃索美拉唑 兰索拉唑 雷贝拉唑 医学 内科学 胃肠病学 回顾性队列研究 质子抑制剂泵 肾功能 药理学 奥美拉唑 细胞色素P450 新陈代谢
作者
Rika Fukui,Satoshi Noda,Yoshito Ikeda,Yuichi Sawayama,Tomohiro Terada,Yoshihisa Nakagawa,Shin–ya Morita
出处
期刊:Clinical Pharmacology & Therapeutics [Wiley]
卷期号:115 (5): 1141-1151 被引量:2
标识
DOI:10.1002/cpt.3183
摘要

Proton pump inhibitors (PPIs) have recently been reported to be linked with nephrotoxicity. PPIs are metabolized mainly or partly by cytochrome P450 2C19 (CYP2C19). However, the relationship between CYP2C19 genetic polymorphism and PPI-induced nephrotoxicity is unclear. In this study, we aimed to analyze the association between the time of occurrence of renal injury by PPIs, including lansoprazole, esomeprazole, rabeprazole, and vonoprazan, and CYP2C19 metabolizer status classified by CYP2C19 genotypes. Patients prescribed PPIs were reviewed in this retrospective cohort study. The primary outcome was the time to a 30% decrease in estimated glomerular filtration rate (eGFR) from baseline. In patients treated with lansoprazole, the time to a 30% decrease in eGFR for the CYP2C19 poor metabolizer (PM) group was significantly shorter than that for the non-PM group (hazard ratio for PM vs. non-PM, 2.43, 95% confidence interval, 1.21 to 4.87, P = 0.012). In contrast, in patients that received esomeprazole, rabeprazole, or vonoprazan, no significant differences were found in the time to a 30% decrease in eGFR between non-PM and PM groups. The adjusted hazard ratios for the time to a 30% eGFR decrease in patients treated with lansoprazole were significantly higher for CYP2C19 PM, hypertension, and a history of myocardial infarction. In conclusion, this retrospective study showed that CYP2C19 metabolizer status was associated with the time to a 30% eGFR decrease in patients treated with lansoprazole, but not with esomeprazole, rabeprazole, or vonoprazan.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赘婿应助科研通管家采纳,获得10
35秒前
36秒前
西柚柠檬完成签到 ,获得积分10
44秒前
心系天下完成签到 ,获得积分10
47秒前
Alex-Song完成签到 ,获得积分0
52秒前
不秃燃的小老弟完成签到 ,获得积分10
2分钟前
2分钟前
Owen应助科研通管家采纳,获得10
2分钟前
年年有余完成签到,获得积分10
2分钟前
胖小羊完成签到 ,获得积分10
3分钟前
4分钟前
领导范儿应助科研通管家采纳,获得10
4分钟前
4分钟前
juan完成签到 ,获得积分10
5分钟前
学术小垃圾完成签到,获得积分10
5分钟前
叁月二完成签到 ,获得积分10
5分钟前
6分钟前
科研通AI2S应助科研通管家采纳,获得10
6分钟前
大模型应助科研通管家采纳,获得10
6分钟前
xingsixs完成签到 ,获得积分10
6分钟前
AprilLeung完成签到 ,获得积分10
7分钟前
8分钟前
深情安青应助科研通管家采纳,获得10
8分钟前
迷茫的一代完成签到,获得积分10
9分钟前
魔笛的云宝完成签到 ,获得积分10
9分钟前
www完成签到,获得积分10
9分钟前
10分钟前
NexusExplorer应助科研通管家采纳,获得10
10分钟前
Akitten发布了新的文献求助10
11分钟前
啥时候吃火锅完成签到 ,获得积分0
12分钟前
上官若男应助科研通管家采纳,获得30
12分钟前
斯文败类应助科研通管家采纳,获得10
12分钟前
李爱国应助科研通管家采纳,获得10
12分钟前
科研通AI2S应助科研通管家采纳,获得10
12分钟前
赘婿应助科研通管家采纳,获得10
12分钟前
田様应助精明晓刚采纳,获得10
12分钟前
13分钟前
精明晓刚发布了新的文献求助10
13分钟前
科研通AI2S应助科研通管家采纳,获得10
14分钟前
coolplex完成签到 ,获得积分10
14分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990423
求助须知:如何正确求助?哪些是违规求助? 3532158
关于积分的说明 11256513
捐赠科研通 3271046
什么是DOI,文献DOI怎么找? 1805207
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234